デフォルト表紙
市場調査レポート
商品コード
1325016

血小板凝集装置の世界市場

Platelet Aggregation Devices

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 196 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
血小板凝集装置の世界市場
出版日: 2023年08月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 196 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

血小板凝集装置の世界市場は2030年までに8億230万米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に5億3,700万米ドルと推定される血小板凝集装置の世界市場は、2030年には8億230万米ドルに達すると予測され、2022年から2030年にかけてCAGR 5.1%で成長すると予測されます。本レポートで分析されているセグメントの一つであるシステムは、CAGR 6.1%を記録し、分析期間終了時には4億2,320万米ドルに達すると予測されています。現在進行中のパンデミック後の回復を考慮し、試薬セグメントの成長は今後8年間のCAGRを4.3%に修正しました。

米国市場は推定1億5,890万米ドル、中国はCAGR4.7%で成長予測

米国の血小板凝集装置市場は、2022年には1億5,890万米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR 4.7%で推移し、2030年までに1億3,930万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ4.5%と4.2%の成長が予測されています。欧州では、ドイツがCAGR約3.8%で成長すると予測されています。

調査対象企業の例

  • Aggredyne, Inc.
  • Bio/Data Corporation
  • F. Hoffmann-La Roche AG
  • Helena Laboratories Corporation
  • SENTINEL CH. SpA
  • Siemens AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • 世界のその他の地域

第4章 競合

目次
Product Code: MCP14028

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Platelet Aggregation Devices Market to Reach $802.3 Million by 2030

In the changed post COVID-19 business landscape, the global market for Platelet Aggregation Devices estimated at US$537 Million in the year 2022, is projected to reach a revised size of US$802.3 Million by 2030, growing at aCAGR of 5.1% over the period 2022-2030. Systems, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$423.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $158.9 Million, While China is Forecast to Grow at 4.7% CAGR

The Platelet Aggregation Devices market in the U.S. is estimated at US$158.9 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$139.3 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.5% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Select Competitors (Total 46 Featured) -

  • Aggredyne, Inc.
  • Bio/Data Corporation
  • F. Hoffmann-La Roche AG
  • Helena Laboratories Corporation
  • SENTINEL CH. SpA
  • Siemens AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Platelet Aggregation Devices - Global Key Competitors Percentage Market Share in 2020 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2020 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Platelet Aggregation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Accessories & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Accessories & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 17: World Platelet Aggregation Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 19: USA 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: Canada 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • JAPAN
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Japan 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • CHINA
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: China 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • EUROPE
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 43: Europe 8-Year Perspective for Platelet Aggregation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • FRANCE
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: France 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 52: France Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: France 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • GERMANY
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Germany 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Germany 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Italy 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Italy 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • UNITED KINGDOM
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: UK 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 70: UK Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: UK 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: Rest of Europe 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Platelet Aggregation Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Product - Systems, Reagents and Accessories & Consumables - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Rest of World 8-Year Perspective for Platelet Aggregation Devices by Product - Percentage Breakdown of Value Sales for Systems, Reagents and Accessories & Consumables for the Years 2023 & 2030
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by Application - Clinical and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Rest of World 8-Year Perspective for Platelet Aggregation Devices by Application - Percentage Breakdown of Value Sales for Clinical and Research for the Years 2023 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Platelet Aggregation Devices by End-Use - Hospitals and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of World 8-Year Perspective for Platelet Aggregation Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Laboratories for the Years 2023 & 2030

IV. COMPETITION